Column: What got lost in a year of hype about obesity drugs
This year, the incredible potential of obesity medicines like Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Zepbound started to come into view. The drugs work so well for so ma…
This year, the incredible potential of obesity medicines like Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Zepbound started to come into view. The drugs work so well for so ma…